dicarbethoxydihydrocollidine has been researched along with transforming growth factor beta in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Denk, H; Factor, VM; Fuchsbichler, A; Preisegger, KH; Stumptner, C; Thorgeirsson, SS | 1 |
| Alvarez-Barrientos, A; del Castillo, G; Fabregat, I; Factor, VM; Fernández, M; Sánchez, A; Thorgeirsson, SS | 1 |
| Bian, Z; Chen, X; Fang, J; Friedman, S; Gershwin, ME; Guo, C; Ma, X; Miao, Q; Peng, Y; Qiu, D; Shen, L; Tang, R; Wang, Q; Xu, J; Yang, F; Zhang, H; Zhong, W | 1 |
| Aseem, SO; Banales, JM; Chi, C; Chowdhury, S; De Assuncao, TM; Hamdan, FH; Huebert, RC; Jalan-Sakrikar, N; Johnsen, SA; Navarro-Corcuera, A; Shah, VH | 1 |
| Cai, X; Dong, H; Gu, T; Guo, Y; Li, B; Li, F; Lu, L; Shen, B; Shen, Z; Xu, X; Zhu, J | 1 |
5 other study(ies) available for dicarbethoxydihydrocollidine and transforming growth factor beta
| Article | Year |
|---|---|
Atypical ductular proliferation and its inhibition by transforming growth factor beta1 in the 3,5-diethoxycarbonyl-1,4-dihydrocollidine mouse model for chronic alcoholic liver disease.
Topics: Animals; Bile Ducts, Intrahepatic; Cell Division; Chemical and Drug Induced Liver Injury; Chronic Disease; Common Bile Duct; Dicarbethoxydihydrocollidine; Disease Models, Animal; Epithelial Cells; Hepatectomy; Ligation; Liver; Liver Diseases, Alcoholic; Liver Regeneration; Mice; Mice, Transgenic; Transforming Growth Factor beta | 1999 |
Deletion of the Met tyrosine kinase in liver progenitor oval cells increases sensitivity to apoptosis in vitro.
Topics: Animals; Apoptosis; Cell Survival; Dicarbethoxydihydrocollidine; Hepatocyte Growth Factor; Hepatocytes; Indicators and Reagents; Mice; Proto-Oncogene Proteins c-met; Signal Transduction; Stem Cells; Transforming Growth Factor beta | 2008 |
Treatment of cholestatic fibrosis by altering gene expression of Cthrc1: Implications for autoimmune and non-autoimmune liver disease.
Topics: Animals; Autoimmune Diseases; Cell Line; Cholestasis, Intrahepatic; Extracellular Matrix Proteins; Gene Expression Regulation; Genetic Therapy; Hepatic Stellate Cells; Humans; Liver Cirrhosis; Liver Diseases; Mice; Mice, Knockout; Pyridines; Smad3 Protein; Transforming Growth Factor beta | 2015 |
Epigenomic Evaluation of Cholangiocyte Transforming Growth Factor-β Signaling Identifies a Selective Role for Histone 3 Lysine 9 Acetylation in Biliary Fibrosis.
Topics: Acetylation; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Bile Ducts; Cell Line; Chromatin Immunoprecipitation Sequencing; Disease Models, Animal; Epigenesis, Genetic; Epigenomics; Gene Knockdown Techniques; Histone Acetyltransferases; Histones; Humans; Liver Cirrhosis, Biliary; Mice; Mice, Knockout; Myofibroblasts; Primary Cell Culture; Pyridines; RNA-Seq; Signal Transduction; Transforming Growth Factor beta | 2021 |
TGF-β/YB-1/Atg7 axis promotes the proliferation of hepatic progenitor cells and liver fibrogenesis.
Topics: Animals; Autophagy; Autophagy-Related Protein 7; Cell Proliferation; Chemical and Drug Induced Liver Injury; Choline Deficiency; Disease Models, Animal; Ethionine; Extracellular Matrix; Gene Expression Regulation; Liver; Liver Cirrhosis; Mice, Knockout; Microscopy, Electron, Transmission; Pyridines; Stem Cells; Transcription Factors; Transforming Growth Factor beta | 2022 |